List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 83 studies with search of: "Mesna"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Effects of Mesna on Homocysteine in Kidney Failure
Condition: End Stage Renal Disease
Interventions: Drug: Mesna;   Other: Saline
2 Completed MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
Conditions: Chronic Renal Insufficiency;   Serum Creatinine Concentration;   Contrast Media Exposition
Intervention: Drug: sodium 2-mercaptoethane sulfonate
3 Completed A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin;   Drug: ifosfamide;   Drug: mesna
4 Active, not recruiting Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Lymphoma
Interventions: Drug: Bortezomib;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna
5 Not yet recruiting Vasodilators and Anti-Oxidant Therapy in Early ATN
Condition: Acute Renal Failure
Intervention: Drug: Fenoldopam Mesylate and/or MESNA
6 Active, not recruiting Chemically Assisted Capsulectomy-A New Clinical Approach
Condition: Capsular Contracture
Intervention: Drug: Mesna
7 Active, not recruiting Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   B-Cell Non-Hodgkin's Lymphoma
Intervention: Drug: Rituximab, Ifosfamide, Carboplatin, VP-16, Mesna, G-CSF, Stem Cell Transplant
8 Recruiting Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: mesna;   Drug: methotrexate;   Drug: vincristine sulfate
9 Recruiting Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Ara-C;   Drug: Dexamethasone;   Drug: G-CSF;   Drug: Doxil
10 Recruiting Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: bortezomib, dexamethasone, ifosfamide;   Drug: mesna, cisplatin, etoposide, rituximab
11 Recruiting T-Reg Cell Kinetics for Patients Receiving Stem Cell Transplant From Mismatched Related or One Antigen Mismatched Unrelated Donors
Conditions: Leukemia;   Hodgkin Lymphoma;   Non Hodgkin Lymphoma;   Myelodysplastic Disease;   Myeloproliferative Disorders
Interventions: Drug: Ara C;   Drug: Cyclophosphamide;   Drug: MESNA;   Procedure: TBI;   Biological: Campath-1h;   Procedure: Stem Cell Infusion;   Drug: Tacrolimus;   Drug: Methotrexate
12 Active, not recruiting Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Conditions: Burkitt Lymphoma;   Non-Hodgkins Lymphoma;   Atypical Burkitt Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Leucovorin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Mesna
13 Recruiting Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies
Conditions: Sickle Cell Disease;   HEMOGLOBIN SS;   HEMOGLOBIN SC;   Hemoglobin Sb0/+
Interventions: Procedure: ALLOGENEIC BMT/SCT Infusion;   Drug: Busulfan;   Biological: Campath 1H;   Drug: Cyclophosphamide and Mesna
14 Recruiting Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Lymphocytic, Acute, T-Cell;   Juvenile Myelomonocytic Leukemia Lymphoblastic;   T-Cell Lymphoblastic Lymphoma;   Myelodysplastic Syndrome
Interventions: Procedure: Haploidentical donor derived natural killer cell infusion;   Drug: Chemotherapy (Cyclophosphamide, Fludarabine, Interleukin-2, Mesna);   Device: CliniMACS
15 Active, not recruiting Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: mesna;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy;   Radiation: radioisotope therapy
16 Active, not recruiting Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: mesna;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: brachytherapy;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
17 Active, not recruiting Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: asparaginase;   Drug: cyclophosphamide;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: liposomal cytarabine;   Drug: mercaptopurine;   Drug: mesna;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thiotepa;   Drug: vincristine sulfate;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
18 Active, not recruiting High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: mesna;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
19 Active, not recruiting Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: mesna;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
20 Active, not recruiting Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: dexamethasone;   Drug: etoposide;   Drug: idarubicin;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: mesna;   Drug: methotrexate;   Drug: pegaspargase;   Drug: therapeutic hydrocortisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services